UA86741C2 - Амброксол для лечения боли в полости рта и глотки - Google Patents

Амброксол для лечения боли в полости рта и глотки

Info

Publication number
UA86741C2
UA86741C2 UA20040907789A UA20040907789A UA86741C2 UA 86741 C2 UA86741 C2 UA 86741C2 UA 20040907789 A UA20040907789 A UA 20040907789A UA 20040907789 A UA20040907789 A UA 20040907789A UA 86741 C2 UA86741 C2 UA 86741C2
Authority
UA
Ukraine
Prior art keywords
ambroxol
mouth
painful conditions
pharyngeal cavity
treating painful
Prior art date
Application number
UA20040907789A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Анке Эсперестер
Уве Пшорн
Жан-Мишель Викс
Original Assignee
Бьёрингер Ингельхайм Фарма Гмбх & Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27740434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA86741(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бьёрингер Ингельхайм Фарма Гмбх & Ко. Кг filed Critical Бьёрингер Ингельхайм Фарма Гмбх & Ко. Кг
Publication of UA86741C2 publication Critical patent/UA86741C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UA20040907789A 2002-02-27 2003-02-25 Амброксол для лечения боли в полости рта и глотки UA86741C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208313A DE10208313A1 (de) 2002-02-27 2002-02-27 Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum

Publications (1)

Publication Number Publication Date
UA86741C2 true UA86741C2 (ru) 2009-05-25

Family

ID=27740434

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20040907789A UA86741C2 (ru) 2002-02-27 2003-02-25 Амброксол для лечения боли в полости рта и глотки

Country Status (21)

Country Link
EP (1) EP1480626A1 (de)
JP (1) JP2005518435A (de)
KR (1) KR20040084944A (de)
CN (1) CN1638749A (de)
AR (1) AR038698A1 (de)
AU (1) AU2003210345B2 (de)
BR (1) BR0308038A (de)
CA (1) CA2477105A1 (de)
DE (1) DE10208313A1 (de)
EC (1) ECSP045242A (de)
IS (1) IS7417A (de)
MX (1) MXPA04008220A (de)
MY (1) MY144781A (de)
PE (1) PE20030830A1 (de)
PL (1) PL371584A1 (de)
RU (1) RU2311176C2 (de)
TW (1) TW200306804A (de)
UA (1) UA86741C2 (de)
UY (1) UY27679A1 (de)
WO (1) WO2003072094A1 (de)
ZA (1) ZA200405635B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
JP2005120063A (ja) * 2003-10-14 2005-05-12 Boehringer Ingelheim Pharma Gmbh & Co Kg 咽頭における炎症の治療のためのアンブロキソール
ITMI20032462A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Metodo per preparare una caramella contenente ambroxolo e la caramella cosi' ottenuta
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
JP2007084471A (ja) * 2005-09-21 2007-04-05 Sunstar Inc 口腔用組成物および口腔用製品の選択方法
EP2015761A4 (de) * 2006-03-29 2009-07-29 Naveh Pharma 1996 Ltd Verfahren und zusammensetzung zur behandlung von halsentzündung
JP5765934B2 (ja) * 2009-12-28 2015-08-19 サンスター株式会社 口腔用組成物
JP6171683B2 (ja) * 2012-08-03 2017-08-02 大正製薬株式会社 固形製剤
CN105769908B (zh) * 2016-05-06 2019-03-01 湖北凤凰白云山药业有限公司 一种化痰止咳的药物及其制备方法
WO2018089797A1 (en) 2016-11-14 2018-05-17 Mingwu Wang Formulations for the treatment of ocular surface diseases and related methods
CN106727621A (zh) * 2016-11-22 2017-05-31 郑州仁宏医药科技有限公司 一种治疗牙痛的西药散剂
JP6844394B2 (ja) * 2017-04-14 2021-03-17 大正製薬株式会社 固形組成物
EP3415143A1 (de) 2017-06-16 2018-12-19 Kai-Uwe Kern Bromhexin zur behandlung von schmerz

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138020B1 (de) * 1983-09-17 1992-06-03 Dr. Karl Thomae GmbH Antiadhäsive Prophylactica und Arzneimittel enthaltend ein sekretolytisch wirksames Benzylaminderivat
DE3445226A1 (de) * 1983-12-14 1985-08-01 Reifenrath, Rainer Richard Otto, Dr.med., 7920 Heidenheim Pharmazeutisches erzeugnis zur behandlung und prophylaxe von infektionen sowie von husten und obstruktiven atemwegserkrankungen
US5122540A (en) * 1986-02-28 1992-06-16 W. Keith R. Watson Method and composition for treating warts and throat soreness with DMSO and citric acid
DE4415553A1 (de) * 1994-05-03 1995-11-09 Behringwerke Ag Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
WO1997041832A1 (fr) * 1996-05-02 1997-11-13 Taisho Pharmaceutical Co., Ltd. Suspension de medicament acide difficilement soluble dans l'eau
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
JP2001151677A (ja) * 1999-11-26 2001-06-05 Taisho Pharmaceut Co Ltd 咽頭用組成物
DE20102817U1 (de) * 2000-02-23 2001-06-07 Bolder Arzneimittel GmbH, 50968 Köln Lutsch- und Kaupastillen mit Cyclodextrin
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics

Also Published As

Publication number Publication date
RU2311176C2 (ru) 2007-11-27
AU2003210345B2 (en) 2009-01-29
AR038698A1 (es) 2005-01-26
EP1480626A1 (de) 2004-12-01
JP2005518435A (ja) 2005-06-23
CA2477105A1 (en) 2003-09-04
MY144781A (en) 2011-11-15
TW200306804A (en) 2003-12-01
PE20030830A1 (es) 2003-10-31
UY27679A1 (es) 2003-09-30
WO2003072094A1 (de) 2003-09-04
AU2003210345A1 (en) 2003-09-09
MXPA04008220A (es) 2004-11-26
PL371584A1 (en) 2005-06-27
RU2004129284A (ru) 2005-06-10
CN1638749A (zh) 2005-07-13
DE10208313A1 (de) 2003-09-11
BR0308038A (pt) 2004-12-28
IS7417A (is) 2004-08-19
KR20040084944A (ko) 2004-10-06
ZA200405635B (en) 2005-05-31
ECSP045242A (es) 2004-09-28

Similar Documents

Publication Publication Date Title
EG25822A (en) Quinolinyl-pyrrolopyrazoles
DE60327089D1 (de) Systeme zum verschieben und/oder zurückhalten von gewebe in den oberen atemwegen
HK1064921A1 (en) Sustained release formulations of oxymorphone
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
UA86741C2 (ru) Амброксол для лечения боли в полости рта и глотки
GEP20063905B (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
GEP20074047B (en) Pramipexole once-daily dosage form
MXPA04003666A (es) Uso de flibanserina para tratamiento de trastornos sexuales.
GB2431346C (en) A combination composition comprising paracetamol and ibuprofen
HK1061975A1 (en) Novel method and compostions for local treatment of meniere's disease, tinnitus and/or hearing loss
CY1114448T1 (el) Φαρμακευτικες συνθεσεις και χρηση αυτων στην αγωγη της γυναικειας σεξουαλικης δυσλειτουργιας
MX2007005581A (es) Regimen de dosificacion mejorada de temozolomida para el tratamiento de cancer con base en el nivel de o6-metilguanidi-adn metiltransferasa del paciente.
MXPA05011472A (es) Uso de derivados de azetidincarboxamida en terapia.
SG148194A1 (en) Compositions for the treatment of affections of the oral cavity and upper respiratory tract
TW200508199A (en) Novel compound
ATE501719T1 (de) Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
EP1262197A3 (de) Kombinationstherapie zur Behandlung von Schlafstörungen, Schlaflosigkeit inbegriffen
SE9902597D0 (sv) New use
NZ514014A (en) Method of treating sleep apnoea
HUP0402326A2 (hu) Gyógyszerkészítmény addikció megelőzésére fájdalom kezelésében
ATE382357T1 (de) Analgetikum für neugeborene und föten
HUP0102507A2 (hu) Paroxetin alkalmazása a dohányzás abbahagyásának elősegítésére, illetve a visszaeső dohányzás csökkentésére vagy megelőzésére szolgáló gyógyszerkészítmények előállítására
MX2008002021A (es) Metodos y composiciones para suavizar tejidos nasales y orales.
MX2007004040A (es) Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.